130 related articles for article (PubMed ID: 1793779)
1. Hydroxyproline in the oesophageal mucosa of patients with progressive systemic sclerosis during omeprazole-induced healing of reflux oesophagitis.
Hendel L
Aliment Pharmacol Ther; 1991 Oct; 5(5):471-80. PubMed ID: 1793779
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in oesophageal mucosal injury in a reflux oesophagitis model of rats.
Masaka T; Iijima K; Endo H; Asanuma K; Ara N; Ishiyama F; Asano N; Koike T; Imatani A; Shimosegawa T
Gut; 2013 Jan; 62(1):6-14. PubMed ID: 22287598
[TBL] [Abstract][Full Text] [Related]
3. Oesophageal motility and gastro-oesophageal reflux before and after healing of reflux oesophagitis. A study using 24 hour ambulatory pH and pressure monitoring.
Timmer R; Breumelhof R; Nadorp JH; Smout AJ
Gut; 1994 Nov; 35(11):1519-22. PubMed ID: 7828965
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis.
Hendel L; Hage E; Hendel J; Stentoft P
Aliment Pharmacol Ther; 1992 Oct; 6(5):565-77. PubMed ID: 1420748
[TBL] [Abstract][Full Text] [Related]
5. Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.
Dehn TC; Shepherd HA; Colin-Jones D; Kettlewell MG; Carroll NJ
Gut; 1990 May; 31(5):509-13. PubMed ID: 2190864
[TBL] [Abstract][Full Text] [Related]
6. Increased release of interleukin-6 by oesophageal mucosa in children with reflux oesophagitis.
Corrado G; Zicari A; Cavaliere M; Rea P; Pacchiarotti C; Cerroni F; Pontieri G; Cardi E
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):839-43. PubMed ID: 10514114
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S
Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777
[TBL] [Abstract][Full Text] [Related]
8. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.
Holloway RH; Dent J; Narielvala F; Mackinnon AM
Gut; 1996 May; 38(5):649-54. PubMed ID: 8707107
[TBL] [Abstract][Full Text] [Related]
9. Acid clearance and oesophageal sensitivity in patients with progressive systemic sclerosis.
Basilisco G; Barbera R; Molgora M; Vanoli M; Bianchi P
Gut; 1993 Nov; 34(11):1487-91. PubMed ID: 8244129
[TBL] [Abstract][Full Text] [Related]
10. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Aliment Pharmacol Ther; 1988 Jun; 2(3):221-7. PubMed ID: 2979246
[TBL] [Abstract][Full Text] [Related]
11. Histological improvement of oesophagitis after Nissen fundoplication.
Luostarinen ME; Mattila JJ; Auvinen OL; Matikainen MJ; Isolauri JO
Ann Med; 1998 Dec; 30(6):547-52. PubMed ID: 9920357
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid profile of oesophageal mucosa in children with gastro-oesophageal reflux disease.
D'Eufemia P; Celli M; Finocchiaro R; Troiani P; Tote J; Giardini O; Corrado G
Dig Liver Dis; 2003 Oct; 35(10):694-700. PubMed ID: 14620617
[TBL] [Abstract][Full Text] [Related]
13. Famotidine in the management of acid-reflux oesophagitis: a multicentre study.
Bovero E; Poletti M; Iaquinto G; Giardulo N; Zambelli A; Pisano G; Cheli R
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():145-8. PubMed ID: 2083926
[TBL] [Abstract][Full Text] [Related]
14. Chronic oesophagitis in the cat.
Poorkhalkali N; Rich HG; Jacobson I; Amaral J; Migliori S; Chrostek C; Biancani P; Cabero JL; Helander HF
Scand J Gastroenterol; 2001 Sep; 36(9):904-9. PubMed ID: 11521978
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of omeprazole treatment in gastro-oesophageal reflux disease.
Hendel J; Hendel L; Hage E; Hendel J; Aggestrup S; Nielsen OH
Eur J Gastroenterol Hepatol; 1996 May; 8(5):417-20. PubMed ID: 8804867
[TBL] [Abstract][Full Text] [Related]
16. Effect of different doses of omeprazole on 24-hour oesophageal acid exposure in patients with gastro-oesophageal reflux.
Robinson M; Maton PN; Allen ML; Humphries TJ; McIntosh D; Cagliola AJ; Bradstreet TE
Aliment Pharmacol Ther; 1991 Dec; 5(6):645-51. PubMed ID: 1782307
[TBL] [Abstract][Full Text] [Related]
17. Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin, on experimental reflux oesophagitis in rats.
Rao CV; Vijayakumar M
Eur J Pharmacol; 2008 Jul; 589(1-3):233-8. PubMed ID: 18547560
[TBL] [Abstract][Full Text] [Related]
18. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
[TBL] [Abstract][Full Text] [Related]
19. Prolonged remission of oesophagitis does not alter the magnitude of oesophageal acid exposure.
Singh P; Taylor RH; Colin-Jones DG
Scand J Gastroenterol; 1994 Jan; 29(1):11-6. PubMed ID: 8128170
[TBL] [Abstract][Full Text] [Related]
20. The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats.
Min YS; Yim SH; Bai KL; Choi HJ; Jeong JH; Song HJ; Park SY; Ham I; Whang WK; Sohn UD
Auton Autacoid Pharmacol; 2005 Jul; 25(3):85-91. PubMed ID: 15955027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
